NeuBase Therapeutics (NBSE) Q4 2022 Earnings

14FebConfirmed
May 22
Aug 22
Dec 22
Q4 2022
-0.3
-0.24
-0.19
-0.13

Details

Expected EPS
-0.2
Actual EPS
-0.13
Surprise EPS
0.07
Surprise Percent
+35%

Description

NeuBase Therapeutics (NBSE) has reported earnings of -0.13 per share for Q4 2022.

0 Comments

Share your thoughts